Daewoong sells calcium product of KRW 72.8 billion to Abbott
On the 2nd, Daewoong Pharmaceutical officially announced a KRW 72.8 billion exclusive sales agreement of ‘Pitavastatin Calcium Tab’ in 4 East Asian countries, including Thailand, with the global pharmaceutical company, Abbott.
The upfront payment includes royalties and 10-year collective exports...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
